Stocks / Pharmaceuticals
TEVAPharmaceuticals
Teva Pharmaceutical Industries Limited
$39.161d +1.6%5d +7.7%settled close · 2026-09-17
Mkt cap $34B (3/25)β 0.0752w $30–39Shares 1.16BInd. Pharmaceutical PreparationsNYSE since 1982Emp. 32,842HQ Tel Avivtevapharm.com
The tape, with the calls on it
Who said what, and what TEVA did next
Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.
bullish
bearish
both sides
Who’s talkingIdea Scout · free
Who’s talking about TEVA
1 longlatest 2026-02-27
| Date | Voice | Stance | Venue | Thesis |
|---|---|---|---|---|
| 2026-02-27 | Stanley DruckenmillerChairman/CEO, Duquesne Family Office | Bullish | interview | Teva is re-rating from 6x to 12x earnings as new management (Richard Francis) transitions the company from… |
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where TEVA’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-16 | ||||||
| 2026-08-19 | ||||||
| 2026-07-30 | ||||||
| 2026-07-29 | ||||||
| 2026-07-06 | ||||||
| 2026-06-30 | ||||||
| 2026-06-23 | ||||||
| 2026-06-18 | ||||||
| 2026-06-17 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
TEVA is in this morning’s Brief.
Get The Brief — $20/mo →